Synthesis 2024; 56(23): 3660-3668
DOI: 10.1055/s-0040-1720141
paper

Synthesis, Isolation and Characterization of Nine Pharmacopeial Impurities Related to the Active Pharmaceutical Ingredient Olsalazine Sodium

Jagdish Chavan
a   API R&D Centre, Emcure Pharmaceuticals Limited, IT-BT Park, Phase II, M.I.D.C., Hinjewadi, Pune 411 057, Maharashtra, India
,
Sudhir Chaskar
a   API R&D Centre, Emcure Pharmaceuticals Limited, IT-BT Park, Phase II, M.I.D.C., Hinjewadi, Pune 411 057, Maharashtra, India
,
Hanmant Vedpathak
a   API R&D Centre, Emcure Pharmaceuticals Limited, IT-BT Park, Phase II, M.I.D.C., Hinjewadi, Pune 411 057, Maharashtra, India
,
Venkat Suryawanshi
b   Department of Chemistry, PG and Research Centre, Shri Chhatrapati Shivaji College, Omerga, Dharashiv 413 606, Maharashtra, India
,
a   API R&D Centre, Emcure Pharmaceuticals Limited, IT-BT Park, Phase II, M.I.D.C., Hinjewadi, Pune 411 057, Maharashtra, India
,
Ashok Chaudhari
a   API R&D Centre, Emcure Pharmaceuticals Limited, IT-BT Park, Phase II, M.I.D.C., Hinjewadi, Pune 411 057, Maharashtra, India
,
Chinmoy Pramanik
a   API R&D Centre, Emcure Pharmaceuticals Limited, IT-BT Park, Phase II, M.I.D.C., Hinjewadi, Pune 411 057, Maharashtra, India
,
Abhijit Roychowdhury
a   API R&D Centre, Emcure Pharmaceuticals Limited, IT-BT Park, Phase II, M.I.D.C., Hinjewadi, Pune 411 057, Maharashtra, India
› Institutsangaben


Abstract

Olsalazine sodium is an anti-inflammatory agent used to treat ulcerative colitis. Both British and European Pharmacopoeia list nine process-related impurities in their monographs. Quantification of the impurities in the final synthesized active pharmaceutical ingredient (API) is required to meet the quality standards set by the International Council for Harmonisation (ICH). Both literature reports and commercial vendors for these impurities are few and far between. The present report describes the synthesis, isolation, purification and characterization of these nine pharmacopeial impurities.

Supporting Information



Publikationsverlauf

Eingereicht: 22. Juli 2024

Angenommen nach Revision: 19. September 2024

Artikel online veröffentlicht:
16. Oktober 2024

© 2024. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Swartz ML. Gastroenterol Nurs. 1991; 14: 144
  • 2 Levine DJ, Gonzalez MI, Legendre CM, Runčevski T, Oktawiec J, Colwell KA, Long JR. ChemMedChem 2017; 12: 1739
  • 3 Olsalazine Sodium, In British Pharmacopoeia, Vol. 2 2018; 467-470
  • 4 Chaskar SP, Honparkhe R, Chavan J, Dhumal A, Tripathy NK, Pramanik C, Chaudhari A, Thorat RG, Gurjar MK. J. Heterocycl. Chem. 2023; 60: 1464
    • 5a Cecchetti V, Fravolini A, Fringuelli R, Schiaffella F. Heterocycles 1984; 22: 2293
    • 5b Grygoriv GV, Lega DA, Chernykh VP, Zaprutko L, Gzella AK, Pawełczyk A, Shemchuk LA. RSC Adv. 2018; 8: 37295
    • 5c Peixoto C, Laurin P, Klich M, Dupuis-Hamelin Cl, Mauvais P, Lassaigne P, Bonnefoy A, Musicki B. Tetrahedron Lett. 2000; 41: 1741
    • 5d Veera Reddy A, Rajendiran C, Vaishali N. WO2005/030738, 2005
    • 5e Kalkhambkar RG, Yuvaraj H. Synth. Commun. 2014; 44: 547
    • 5f Arava VR, Siripalli UB. R, Nadkarni V, Chinnapillai R. Beilstein J. Org. Chem. 2007; 3: 20
    • 5g Razzetti G, Mantegazza S, Castaldi G, Allegrini P, Lucchini V, Bologna A. WO2004/063173 A1, 2004
    • 6a Vilaró M, Nieto J, La Parra JR, Almeida MR, Ballesteros A, Planas A, Arsequell G, Valencia G. ACS Comb. Sci. 2015; 17: 32
    • 6b Bumagin NA, Bykov VV. Tetrahedron 1997; 53: 1443
    • 6c Aqueous Organometallic Chemistry . Joó F. Kluwer Academic Publishers; Dordrecht: 2001
    • 6d Aqueous-Phase Organometallic Catalysis . Cornils B, Herrmann WA. Wiley-VCH; Weinheim: 2004
  • 7 Kenawy E.-R, Al-Deyab SS, El-Newehy MH. Molecules 2010; 15: 2257
  • 8 Chuyi Y, Yuemei J, Yixian L, Siyang G. CN105985259A A1, 2016
  • 9 For a chromatogram of the reaction mixture with enriched impurities, please refer to the Supporting Information.